Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cancer Treatment
100%
Protein Kinase
100%
Antisense
100%
DNA Target
100%
Antisense DNA
100%
Targeted Protein
100%
Apoptosis
50%
Gene Expression
50%
Oncogenesis
50%
Cancer Cells
50%
Antisense Oligonucleotides
50%
Cancer Cell Lines
50%
Specific Inhibition
50%
Target-based Approach
50%
Enhanced Expression
50%
Growth Arrest
50%
Tumor Cell Proliferation
50%
Primary Tumor
50%
Sequence Specificity
50%
CAMP-dependent Protein Kinase
50%
Gene Targeting
50%
Leukemia Cells
50%
Tumor Cell Survival
50%
Cell Cycle Deregulation
50%
Holoenzyme
50%
Tyrosine Kinase Signaling
50%
Cell Arrest
50%
Tumor Growth Inhibition
50%
Epithelial Origin
50%
Epithelial Tumors
50%
Leukemia Growth
50%
Medicine and Dentistry
Tumor Progression
100%
Protein Kinases
100%
Complementary DNA
100%
Cyclic AMP Dependent Protein Kinase
100%
Cancer Therapy
100%
Antisense
100%
Radioimmunoassay
100%
Alpha Chain
100%
Gene Targeting
100%
Targeting Protein
100%
Cancer Cell
50%
Programmed Cell Death
50%
Gene Expression
50%
Kinase Signaling
50%
Cell Survival
50%
Tumor Cell
50%
Cancer Treatment
50%
Cancer Cell Line
50%
Primary Tumor
50%
Carcinogenesis
50%
Cell Cycle
50%
Leukemia Cell
50%
Growth Disorder
50%
Protein Tyrosine Kinase
50%
Antisense Oligonucleotide
50%
Tumor
50%
Holoenzyme
50%
Immunology and Microbiology
Antisense
100%
Alpha Chain
100%
Gene Targeting
100%
Radioimmunoassay
100%
Kinase A
100%
Phosphotransferase
75%
Kinase
75%
Tumor Cell
50%
Cell Cycle
25%
Gene Expression
25%
Cell Growth
25%
Cancer Cell
25%
Cancer Cell Line
25%
Cell Survival
25%
Leukemia Cell
25%
Programmed Cell Death
25%
Tyrosine
25%
Biochemistry, Genetics and Molecular Biology
Targeting Protein
100%
Protein Kinase A
100%
Alpha Chain
100%
Antisense
100%
Gene Targeting
100%
Cancer Cell
50%
Tumor Progression
50%
Protein Kinases
50%
Carcinogenesis
25%
Gene Expression
25%
Cell Cycle
25%
Cyclic Adenosine Monophosphate
25%
Cell Survival
25%
Receptor Tyrosine Kinase
25%
Tyrosine Kinase
25%
Oligonucleotide
25%
Programmed Cell Death
25%
Half-Life
25%
Pharmacology, Toxicology and Pharmaceutical Science
Complementary DNA
100%
Malignant Neoplasm
100%
Cyclic AMP Dependent Protein Kinase
100%
Gene Delivery
100%
Radioimmunoassay
100%
Tumor Growth
50%
Protein Kinases
50%
Neoplasm
25%
Leukemia
25%
Carcinogenesis
25%
Growth Disorder
25%
Primary Tumor
25%
Protein Tyrosine Kinase
25%
Antisense Oligonucleotide
25%
Holoenzyme
25%